GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Change In Working Capital

Krebs Biochemicals & Industries (BOM:524518) Change In Working Capital : ₹0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Change In Working Capital?

Krebs Biochemicals & Industries's change in working capital for the quarter that ended in Jun. 2024 was ₹0.0 Mil.

Krebs Biochemicals & Industries's change in working capital for the fiscal year that ended in Mar. 2024 was ₹101.5 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Krebs Biochemicals & Industries Change In Working Capital Historical Data

The historical data trend for Krebs Biochemicals & Industries's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Change In Working Capital Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -155.76 21.08 159.00 -98.38 101.49

Krebs Biochemicals & Industries Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Krebs Biochemicals & Industries Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krebs Biochemicals & Industries Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries Business Description

Traded in Other Exchanges
Address
Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries Headlines

No Headlines